Skip to content
Pharma Observatory a Scientist.com platform

Clinical trial

Response Guided Therapy (RGT) for Boceprevir Combined With Peginterferon Alpha-2b Plus Ribavirin in Naïve Hispanic Patients With Genotype 1 Hepatitis C Infection

NCT01465516 is registered in ClinicalTrials.gov with Arrowhead Regional Medical Center as lead sponsor.

NCT NCT01465516
Email me this page as a PDF

Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.

Get the NCT01465516 report as a PDF

The PDF carries up to 50 rows of each section, where the page shows the first few, with the sources listed. Enter a work email and confirm it from the message we send, and the report follows by email.

Registry record

As filed in ClinicalTrials.gov.

Title
Response Guided Therapy (RGT) for Boceprevir Combined With Peginterferon Alpha-2b Plus Ribavirin in Naïve Hispanic Patients With Genotype 1 Hepatitis C Infection
Lead sponsor
Arrowhead Regional Medical Center
Phase
Observational
Overall status
Terminated
Start date
November 30, 2011
Completion date
December 31, 2013
Enrollment
105 (actual)
Sites
1

Conditions

As the registry lists them; a condition with its own page is linked.

hepatitis c infection